What are the antibiotic coverage options for Methicillin-Resistant Staphylococcus epidermidis (MRSE)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 10, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Methicillin-Resistant Staphylococcus epidermidis (MRSE) antibiotic coverage options are similar to those for MRSA, and include vancomycin, daptomycin, linezolid, ceftaroline, telavancin, tedizolid, and dalbavancin.

Antibiotic Options

  • Vancomycin: should be avoided in patients with renal impairment and when the MRSE isolate shows a MIC for vancomycin ≥ 1.5 mg/mL 1
  • Daptomycin: is a drug of choice for empirical anti-MRSE coverage, with a recommended dose of 10 mg/kg/dose IV once daily 1
  • Linezolid: is also a drug of choice for empirical anti-MRSE coverage, with a recommended dose of 600 mg IV or PO twice daily 1
  • Ceftaroline: is an alternative option for empirical anti-MRSE coverage, with a recommended dose of 600 mg IV every 12 hours 1
  • Telavancin: is an alternative option for empirical anti-MRSE coverage, with a recommended dose of 10 mg/kg/dose IV once daily 1
  • Tedizolid: is an alternative option for empirical anti-MRSE coverage, with a recommended dose of 200 mg IV or PO once daily 1
  • Dalbavancin: is an alternative option for empirical anti-MRSE coverage, with a recommended dose of 1000 mg IV once daily 1

Oral Antibiotic Options

  • Linezolid: is a recommended oral antibiotic option for MRSE, with a dose of 600 mg twice daily 1
  • Tedizolid: is a recommended oral antibiotic option for MRSE, with a dose of 200 mg once daily 1
  • Trimethoprim-sulfamethoxazole (TMP-SMX): is a recommended oral antibiotic option for MRSE, with a dose of 160/800 mg twice daily 1
  • Tetracyclines (doxycycline or minocycline): are recommended oral antibiotic options for MRSE, with a dose of 100 mg twice daily for doxycycline and 200 mg twice daily for minocycline 1

Duration of Therapy

  • The recommended duration of therapy for MRSE is 7-14 days, but should be individualized based on the patient's clinical response 1

From the Research

Antibiotic Coverage Options for Methicillin-Resistant Staphylococcus epidermidis (MRSE)

  • Vancomycin is a commonly used treatment option for MRSE infections 2
  • Netilmicin has been shown to be effective against MRSE clinical isolates, with 100% of MRSE isolates tested being sensitive to netilmicin 3
  • Combination therapies, such as the use of cationic branched polyethylenimine (BPEI) with β-lactam antibiotics, have been found to be effective against MRSE 4
  • Other antibiotics, such as chloramphenicol, may also be effective against MRSE, although resistance rates vary 2, 3

Factors Affecting Antibiotic Resistance in MRSE

  • The use of broad-spectrum antibiotics can select for the emergence of resistant pathogens, including MRSE 2
  • The presence of the mecA gene, which encodes for penicillin-binding protein 2a (PBP2a), is a key factor in β-lactam resistance in MRSE 4
  • Biofilm formation and adherence to inanimate surfaces can also contribute to the difficulty of treating MRSE infections 4

Treatment Considerations for MRSE Infections

  • Vancomycin remains a treatment of choice for MRSE infections, although its use should be optimized to minimize the risk of resistance 2
  • Combination therapies and the use of newer antibiotics, such as netilmicin, may be effective in treating MRSE infections 4, 3
  • Infection control measures, including isolation and proper hand hygiene, are crucial in preventing the spread of MRSE 2

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What is the preferred treatment for Staphylococcus (Staph) bacteremia: parenteral (intravenous) antibiotics versus oral antibiotics?
What antibiotic (abx) should be used and what precautions taken for an in-patient with a detected Staphylococcus species by Polymerase Chain Reaction (PCR) and Gram-positive cocci in pairs and clusters in the aerobic bottle?
What are the initial antibiotic choices for treating infections caused by gram-positive cocci in clusters, such as Staphylococcus aureus?
What is the treatment for secondary muscular infection?
What is the appropriate treatment for an 11-year-old patient with an anal rash, whose swab results are positive for gram-positive cocci and rods, including Escherichia coli, diptheroids, and coagulase-negative Staphylococcus?
What is the role of Renewosome in treating rosacea?
What is the antibiotic treatment for tenosynovitis?
What is the treatment for hypertriglyceridemia?
What is the differential diagnosis for a nontender left neck mass at level 2 in pediatrics (Peds)?
What is the brand name for levothyroxine liquid?
What is the maximum dose for hydralazine?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question